BIAFW BIOAFFINITY TECHNOLOGIES INC
Follow*W EXP 09/07/202 (warrant or right), issuer CIK 1712762
6 managers (6 13F filers) reported a position in BIAFW shares at 2024-12-31, 312,573 shares in all. 1 filer opened a position and 0 filers sold out during the quarter.
- Managers
- 6
- 13F filers
- 6
- New
- 1
- Added
- 3
- Reduced
- 0
- Sold out
- 0
- Shares held by filers
- 312,573
Shares held by filers adds up every 13F filer's report, so a share reported by a parent and by its subsidiary counts twice (H9). Managers counts each filer group once.
13D and 13G filers
No 13D or 13G on this security in the data. Structured 13D/G data starts 2024-12-18.
Insider trades
No Form 4 transaction on this security in the data.
13F holders, Q4 2024
Filers in the available 13F reports with a share position at 2024-12-31, filer groups collapsed to one row (method), largest first. Options and principal amounts are left out. A group row states no % of portfolio, since each member reports its own portfolio: the members' percents are listed under it. A value about 1,000 times or 1/1,000 of the price other filers imply is shown as filed but neither ranks the row nor enters a sum.
| Holder | Shares | Value | % of portfolio | Change | Source |
|---|---|---|---|---|---|
| ARMISTICE CAPITAL, LLC | 204,082 | $68.7K | <0.01% | 0 | 13F-HRTimeline |
| CLEAR STREET LLC | 55,133 | $18.5K | <0.01% | +200 | 13F-HR/ATimeline |
| CITADEL ADVISORS LLCin group CITADEL ADVISORS LLC | 50,245 | $17.1K | <0.01% | +11,065 | 13F-HRTimelineGroup |
| OARSMAN CAPITAL, INC. | 2,448 | $733 | <0.01% | new | 13F-HRTimeline |
| UBS Group AGin group UBS Group AG | 665 | $199 | <0.01% | +198 | 13F-HRTimelineGroup |
| CONCOURSE FINANCIAL GROUP SECURITIES, I… | 0 | $0 | 0% | 0 | 13F-HRTimelineValue filed as zero, left out of ratios. Amount filed as zero, left out of ratios. |